Your browser doesn't support javascript.
loading
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors.
Vidula, Neelima; Rich, Thereasa A; Sartor, Oliver; Yen, Jennifer; Hardin, Aaron; Nance, Tracy; Lilly, Michael B; Nezami, Mohammad Amin; Patel, Sandip P; Carneiro, Benedito A; Fan, Alice C; Brufsky, Adam M; Parker, Barbara A; Bridges, Benjamin B; Agarwal, Neeraj; Maughan, Benjamin L; Raymond, Victoria M; Fairclough, Stephen R; Lanman, Richard B; Bardia, Aditya; Cristofanilli, Massimo.
Afiliação
  • Vidula N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. nvidula@mgh.harvard.edu.
  • Rich TA; Guardant Health, Redwood City, California.
  • Sartor O; Tulane Cancer Center, Tulane University, New Orleans, Louisiana.
  • Yen J; Guardant Health, Redwood City, California.
  • Hardin A; Guardant Health, Redwood City, California.
  • Nance T; Guardant Health, Redwood City, California.
  • Lilly MB; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
  • Nezami MA; Pacific Medical Center of Hope, Fresno, California.
  • Patel SP; University of California San Diego, Moores Cancer Center, La Jolla, California.
  • Carneiro BA; Warren Alpert Medical School, Brown University, Lifespan Cancer Institute, Providence, Rhode Island.
  • Fan AC; Stanford University School of Medicine, Stanford, California.
  • Brufsky AM; University of Pittsburgh Magee Women's Hospital, Pittsburgh, Pennsylvania.
  • Parker BA; University of California San Diego, Moores Cancer Center, La Jolla, California.
  • Bridges BB; St Luke's Mountain States Tumor Institute, Meridian, Idaho.
  • Agarwal N; University of Utah, Salt Lake City, Utah.
  • Maughan BL; University of Utah, Salt Lake City, Utah.
  • Raymond VM; Guardant Health, Redwood City, California.
  • Fairclough SR; Guardant Health, Redwood City, California.
  • Lanman RB; Guardant Health, Redwood City, California.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Cristofanilli M; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Clin Cancer Res ; 26(11): 2546-2555, 2020 06 01.
Article em En | MEDLINE | ID: mdl-32034076
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteína BRCA1 / Proteína BRCA2 / Testes Diagnósticos de Rotina / Ácidos Nucleicos Livres / Mutação / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteína BRCA1 / Proteína BRCA2 / Testes Diagnósticos de Rotina / Ácidos Nucleicos Livres / Mutação / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos